The inhibition of telomere shortening, telomerase up-regulation, hyperactivity of MYC and ATM oncogenes, as well as p16-CDKN2A pathway (CDK4, CCND1, RB) is evidenced to promote uncontrolled proliferation and represents a common cancer cascade [14]. The gene discussed is CDKN2A; the disease is cancer.